X
API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
http://www.pmlive.com/pharma_news/biogens_r_and_d_chief_ehlers_heads_for_the_exit_1311677
http://www.pmlive.com/pharma_news/biogen_loses_another_pipeline_drug_to_toxicity_concerns_1301871
https://www.fiercebiotech.com/biotech/biogen-eisai-throw-out-remaining-alzheimer-s-bace-hope
https://www.prnewswire.com:443/news-releases/new-data-in-2-oral-and-13-poster-presentations-about-eisais-latest-dementia-pipeline-including-ban2401-elenbecestat-and-lemborexant-to-be-presented-at-alzheimers-association-international-conference-300883623.html
https://www.prnewswire.com/news-releases/eisai-to-present-latest-research-about-alzheimers-diseasedementia-pipeline-at-the-14th-international-conference-on-alzheimers--parkinsons-diseases-300816842.html
https://www.biospectrumasia.com/news/25/13083/eisai-to-present-latest-research-on-alzheimers-disease-dementia-pipeline-.html
https://www.reuters.com/article/us-eisai-biogen-alzheimers/eisai-starts-phase-3-trials-for-second-alzheimers-drug-after-firsts-failure-idUSKCN1R303T
http://www.prnewswire.co.uk/news-releases/xingimaging-announces-alzheimers-disease-pet-imaging-in-mainland-china-692149441.html
https://www.fiercebiotech.com/biotech/biogen-and-eisai-s-previously-bleak-alzheimer-s-study-comes-back-positive-results
Market Place
Share 
